These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 3136430

  • 1. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
    Renaudin H, Quentin C, de Barbeyrac B, Bebear C.
    Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
    [Abstract] [Full Text] [Related]

  • 2. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A, Phillips I.
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [Abstract] [Full Text] [Related]

  • 3. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D, O'Hare MD, Robbins MJ, Wall RA, Williams AH, Cremer AW, Ridgway GL, Grüneberg RN.
    Drugs Exp Clin Res; 1985 Nov; 11(5):317-29. PubMed ID: 2941259
    [Abstract] [Full Text] [Related]

  • 4. In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin.
    Van der Auwera P.
    Infection; 1986 Nov; 14(3):142-4. PubMed ID: 2942489
    [Abstract] [Full Text] [Related]

  • 5. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
    Ridgway GL, O'Hare MD, Felmingham D, Grüneberg RN.
    Drugs Exp Clin Res; 1985 Nov; 11(4):259-62. PubMed ID: 2941258
    [Abstract] [Full Text] [Related]

  • 6. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
    Arpi M, Gahrn-Hansen B, Søgaard P, Bentzon MW.
    Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910
    [Abstract] [Full Text] [Related]

  • 7. [Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
    Habiyaremye I, Verbist L, Vandepitte J.
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):800-4. PubMed ID: 3116489
    [Abstract] [Full Text] [Related]

  • 8. Comparative in vitro activities of ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile.
    Edlund C, Nord CE.
    Scand J Infect Dis; 1986 Jun; 18(2):149-51. PubMed ID: 2939556
    [Abstract] [Full Text] [Related]

  • 9. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
    O'Hare MD, Felmingham D, Ridgway GL, Grüneberg RN.
    Drugs Exp Clin Res; 1985 Jun; 11(4):253-7. PubMed ID: 2941257
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
    Davies S, Sparham PD, Spencer RC.
    J Antimicrob Chemother; 1987 May; 19(5):605-9. PubMed ID: 3112094
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.